Status | Study |
Withdrawn |
Study Name: Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2013-02-28 Interventions: Drug: Exenatide Qualifying par |
Completed |
Study Name: Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients Condition: Short Bowel Syndrome Date: 2010-08-02 Interventions: Radiation: Barium follow-through and MR-enterography Assessment of the lack of difference between surgic |
Completed |
Study Name: Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) Condition: Short Bowel Syndrome Date: 2009-06-26 Interventions: Drug: teduglutide 0.05 mg/kg/day subcutaneously taken once per day for 24 months |
Withdrawn |
Study Name: Fiber Use in Pediatric Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2009-06-16 Interventions: Dietary Supplement: guar gum guar gum (20 g/l of formula) for one week |
Withdrawn |
Study Name: Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2009-04-02 Interventions: Drug: Citalopram Citalopram pharmacokinetics will be studi |
Completed |
Study Name: Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects Condition: Short Bowel Syndrome Date: 2008-11-25 Interventions: Drug: teduglutide 0.05 mg/kg/d |
Completed |
Study Name: Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2008-10-06 Interventions: Biological: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R) Oral vaccine for prevention of rotavir |
Terminated |
Study Name: Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS) Condition: Short Bowel Syndrome Date: 2008-08-26 Interventions: Drug: Growth Hormone dosage = 0.05mg/kg/day, in diluent for injection, once a day, for 23 - 54 days. |
Recruiting |
Study Name: Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome Condition: Short Bowel Syndrome Date: 2008-05-05 Interventions: Drug: GLP-2 450 nmol subcutane |
Completed |
Study Name: Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) Condition: Short Bowel Syndrome Date: 2005-09-13 Interventions: Drug: teduglutide 0.05 mg/kg/d |